Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO
PaperCitations, authors & open-access status
Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 11 citations, 2021 year and diamond oa status.
11
Citations
2021
Year
diamond
OA Status